Screening and predicting progression from high-risk mild cognitive impairment to Alzheimer’s disease
Abstract Individuals with mild cognitive impairment (MCI) are clinically heterogeneous, with different risks of progression to Alzheimer’s disease. Regular follow-up and examination may be time-consuming and costly, especially for MRI and PET. Therefore, it is necessary to identify a more precise MR...
Guardado en:
Autores principales: | Xiao-Yan Ge, Kai Cui, Long Liu, Yao Qin, Jing Cui, Hong-Juan Han, Yan-Hong Luo, Hong-Mei Yu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6058335ef7e5431b8d3c9d951ad243de |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease
por: Wenjuan Rui, et al.
Publicado: (2021) -
Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
por: Xiong Jiang, et al.
Publicado: (2021) -
Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer’s disease
por: Li W, et al.
Publicado: (2016) -
A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
por: Leigh A Johnson, et al.
Publicado: (2013) -
Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease
por: Paul Loyd Wheeler, et al.
Publicado: (2021)